Docetaxel
NDC 47335-939, Docetaxel, injection, solution, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 47335-939
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022534
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/47335-939 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOCETAXEL ANHYDROUS160 mg/8mL
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 47335-939-40 | 47335093940 | 1 VIAL, GLASS in 1 CARTON (47335-939-40) / 8 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c85b2c62-3c33-4cbc-8b79-d5e17851a1b4Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=47335-939
Use it
Look up 47335-939 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/47335-939 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 47335-939. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.